Venue: Holiday Inn & Suites Dubai Science Park, an IHG Hotel, Dubai, UAE.
IHG Hotel, Dubai Science Park, Dubai, UAE.
Global Pharmacovigilance Trends and StrategiesSignal Detection and Management
Navigating Complex Regulatory FrameworksGood Pharmacovigilance Practices (GVP): An Overview
FDA and EMA Regulations: A Comparative AnalysisEfficient Adverse Event Reporting
Innovations in Pharmacovigilance: Harnessing Data and TechnologyArtificial Intelligence and Machine Learning in PharmacovigilanceDigital Health and Real-World Evidence
Clinical Trials and PV InterventionEnsuring Data Integrity and Quality Assurance in PV OperationsDrug Labelling and Communication
The Role of Quality Assurance in Drug SafetyImplementing Quality Control Measures for Drug Manufacturing
Innovations in Pharmacovigilance: Harnessing Data and TechnologyArtificial Intelligence and Machine Learning in PharmacovigilanceDigital Health and Real-World Evidence
Clinical Trials and PV InterventionEnsuring Data Integrity and Quality Assurance in PV OperationsDrug Labelling and Communication
The Role of Quality Assurance in Drug SafetyImplementing Quality Control Measures for Drug ManufacturingClinical Pharmacist & Pharmacovigilance Officer
Emirates Drug
Establishment
Head of Pharmacovigilance Hub at Roche CEETRIS,
Middle East & Africa, ROCHE
Managing Director,
PVigilant Health
Program Director & Professor at College of Pharmacy,
Dubai Medical University
Medical Director, Drug Safety
Lovance Biotherapeutics
Co-Founder & Consultant
Composite Pharma
Regional PV Assessor, Regional Centers Unit – Egyptian Drug
Authority (EDA)
CEO & Owner
Pharsafer
Director &
Head of Patient Safety
Ipsen
Ministry of
Health/registration
and Drug Control
Department
Managing Director,
PVigilant Health
Global Vigilance Manager
Julphar Pharma
Ministry of
Health/registration
and Drug Control
Department
General Manager Advisor - Regulatory And Pricing Affairs, Jordan Food And Drug Administration
Managing Director,
PVigilant Health
Director - Pharmacovigilance and Drug Information Department, Ministry of Health, Oman
PharSafer is a Global CRO specialising in all aspects of Clinical & Post Marketing Safety; Medical Affairs; Regulatory Strategy; Auditing; Training; IT Informatics & Development. Established for over 20 years; PharSafer has a wealth of experienced individuals in the Company able to help clients in all areas of vigilance – from case processing to signal detection and from drugs to devices to vaccines; biologics; advanced therapies and cosmetics.
(Till December 5th)
(Till December 5th)
(Till December 5th)
+5% VAT
+5% VAT
Katya Nabeel Ailabouni is a dedicated clinical pharmacist with a Master’s in Clinical Pharmacy from Al Ain University, UAE (2024), and a Bachelor’s in Pharmacy from Philadelphia University, Jordan (1999). Currently, she serves as a Pharmacovigilance Officer and Import/Export Inspector at the UAE Emirates Drug Establishment (EDE). With over 20 years of experience at the Ministry of Health, she has excelled in drug registration, regulatory affairs, and pharmacovigilance. Katya’s commitment to ensuring drug safety and her expertise in managing national PV processes make her a valuable asset to the UAE’s healthcare sector.
Maha Eltemamy, a pharmacist by training, brings 19 years of diversified experience in pharmacovigilance, healthcare compliance, clinical operations, sales, and marketing across both regional and local landscapes.
Maha’s career began with Sanofi-Aventis in 2006 in sales, subsequently joining Roche Egypt in 2008. Her initial roles in sales and marketing provided her with unique insights into patient needs and healthcare system gaps. In 2011, Maha transitioned into pharmacovigilance as a Local Safety Responsible, marking the start of her dedicated journey in ensuring patient safety.
As the current Regional Pharmacovigilance Hub Head, Maha has been instrumental in the creation and growth of the Middle East PV Hub. She is passionate about developing high-performing teams who are purpose driven and has played a crucial role in establishing a connected global PV Hub community. Her leadership in various strategic PAN PV Hub initiatives has been pivotal over the past few years.
Maha’s recent focus has been on shaping the future of a PV-centric ecosystem. She contributed significantly to the co-creation and evolution of Roche International Patient Safety and PAN PV Hubs strategy. Additionally, she has held a prominent leadership role where she was key in the design and realization of the Imagine Safety initiative.
Maha strongly believes that patients and caregivers have the right to get access to the information that influences their treatment journey. Her unwavering commitment to enhancing drug safety underscores her passion for making a meaningful difference in patient care.
Dr. Ahmed Hegazy is a seasoned physician and pharmaceutical medicine expert with over 27 years of extensive experience across sales, medical affairs, marketing, training, and pharmacovigilance in the pharmaceutical industry. He holds a Master’s degree in Pharmaceutical Medicine with First Class Honours for his thesis on Adverse Drug Reactions in the Middle East—recognized with distinction, presented at ISoP 2017, and published in Drug Safety.
His academic journey is enriched with certifications from prestigious institutions including George Washington University (Neurology), Columbia University (Immunology and Transplantation), the Royal College of Physicians (GCP & Clinical Research), Uppsala Monitoring Centre (Pharmacovigilance), and more. He also holds a Mini MBA, and diplomas in Medical Quality and Hospital Management. Additionally, he is an ISO 9001:2015 Lead Auditor (IRCA-accredited) and a Lean Six Sigma Green Belt holder.
Dr. Hegazy served as Head of Global Patient Safety at Merck for seven years, overseeing PV operations across 82 countries with a team across eight nations. His Medical Affairs leadership spans 12+ years across various therapeutic areas, including neurology, oncology, endocrinology, immunology, and infectious diseases.
He is currently the Founder of Pvigilant Health, based in Dubai, and operates as an Executive Consultant in Medical Affairs and Pharmacovigilance for local and global firms. A respected thought leader, he regularly chairs, moderates, and speaks at conferences and trains regulatory bodies, academic institutions, and industry professionals worldwide.
Prof. Dr. Mirza R. Baig is currently working as an Associate Dean- Clinical Affairs at Dubai Pharmacy College for Girls. He did his PhD in Clinical Pharmacy from University Science Malaysia (USM), Malaysia. He worked in Malaysia, India and have international teaching and research experience of about 22 years. He has been named among top scientists in the world in the scientific index 2024-25. He has one German patent 2022 and two US patents 2024, in collaboration with King Abdul Aziz University, Saudi Arabia. He published six books as co-author, related to Clinical Pharmacy and recent one as an editor in Springer publication April 2024 on Drug Development. He published more than 120 research articles in International Journals with a recent paper published in Jan 2025. He has been invited as a chairperson, speaker and moderator to many international conferences and seminars. He is on the editorial board in various international journals, including reviewer for couple of Elsevier journals. He supervised numerous master and PhD students for their research projects. He also reviewed several Master and PhD thesis for Indian and foreign universities as an external examiner. He received many awards in his career, a few of it as, the Distinguished Alumnus Award 2024 from KLE University, India, Best Research Project 2023, in a conference held in Al Ain University, Best Research Project 2019, in a conference held in University of Sharjah, Best Professor in Clinical Pharmacy in Middle East Educational Awards 2018, Best oral presentation in DUPHAT Dubai 2017, Best Quality Poster in 2016 in DUPHAT Dubai, an Outstanding scientist by a research foundation in India 2016, Best oral presentation in Dubai 2015 & 2014, young scientist award in Malaysia in 2013, Best presentation award in IPC, Chennai 2003, in India. His area of research is Pharmacoepidemiology, Drug safety and efficacy, Drug Utilization Studies, Pharmacovigilance, and Public health.
Dr. Tarik Messaoud is a physician and international consultant, advisor, and speaker in pharmacovigilance, regularly contributing to major drug safety congresses in the United States and Canada. He holds a graduate diploma in Clinical Research and Clinical Trial Management from the University of Montreal, Canada.
With 15 years of experience in pharmacovigilance across Canada and the United States, he specializes in oncology drug safety, particularly in immunotherapy, adoptive cell therapy, and checkpoint inhibitor–based cancer treatments. His career includes medical and safety leadership roles at Merck/MSD, GlaxoSmithKline, and Iovance Biotherapeutics focused on patient safety.
Dr. Messaoud brings extensive expertise in global pharmacovigilance regulations, including Health Canada, FDA, ICH, and EMA guidelines.
Dr. Lobna Samy Younes is a distinguished clinical pharmacist and a leading Regional ICSR Assessor at the Egyptian Drug Authority (EDA), where she plays a pivotal role in strengthening national pharmacovigilance systems. Renowned as a national driver of PV capacity building, she founded and leads several high-impact EDA initiatives, including the “Be-Vigilant” program for empowering PV focal points across Egyptian healthcare settings, and the “Agile Mindset for Growth” initiative, which supports the professional development of pharmacy students across Egyptian universities.
Her work has significantly advanced Egypt’s ADR reporting culture, stakeholder engagement, and drug safety awareness across governmental and private sectors. At the EDA, she conducts in-depth safety assessments, manages case investigations, and supports regulatory decision-making through high-quality ICSR collection, processing, and evaluation. She also contributes to national signal detection efforts using tools such as Vigiflow, VigiBase, and VigiLyze, providing real data-driven insights that enhance public health decision-making.
Dr. Lobna holds diplomas in clinical pharmacy, health informatics, and health economics, and is a graduate of Harvard Medical School’s ESCRT program in clinical research. She also holds an MBA in Supply Chain Management, a PMP certification, and credentials in disciplined entrepreneurship and women’s leadership. As an ILO-certified trainer, she continues to champion PV education, national health initiatives, and public safety excellence across Egypt.
Dr. Graeme Ladds has been involved in Drug Safety for the last 35 years holding senior positions in a number of top ten Pharma. As CEO of PharSafer Graeme has established a global Company looking after the safety of many different client product types and has overseen over 100 Regulatory Inspections globally, and understands intimately the requirements for operating a compliant safety system in order to protect patients properly and quickly satisfying the regulations.
Gozde Olkay, is currently working in Boehringer Ingelheim as a Head of Patients Safety and Pharmacovigilance of India Middle East Turkey and Africa region, with coverage of 36 countries.
She is a proud graduate of Istanbul University Faculty of Pharmacy, and then completed her master degree in business administration. She has been working multinational pharmaceutical companies as an expat, over the last 25 years. She had global roles in Germany, Vienna, Istanbul and finally in Dubai.
Prior to her current role, she was leading Emerging Markets in Research and Development Unit of BI, conducting the early phase trials in different therapy areas.
She has moved to PV function in 2019 and became a member of Regional Leadership Team of BI PSPV. She is a true believer in the partnerships and collaborative work and effort which need to be spent collectively with academia, HAs as well as pharmaceuticals in order to leverage the PV understanding and importance within the region.
Gozde is a mother of a 10 years old boy, passionate about cooking, travelling and cinema.
